Amanote Research
Register
Sign In
Combating Acquired TRK Inhibitor Resistance
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2019-047
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 1, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Selective TRK Inhibitor CH7057288 Against TRK Fusion-Driven Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Biochemical Challenges in Combating Antimicrobial Resistance
Biochemistry & Analytical Biochemistry
Targeting AMPK-ULK1-mediated Autophagy for Combating BET Inhibitor Resistance in Acute Myeloid Leukemia Stem Cells
Autophagy
Cell Biology
Molecular Biology
Combating Resistance to DNA Damaging Agents
Oncoscience
Cancer Research
Oncology
A Review on Combating Antibiotic Resistance
International Journal of Medical and Biomedical Studies
Systemic Acquired Resistance
Plant Cell
Plant Science
Cell Biology
Nordic Co-Operation on Combating Antimicrobial Resistance
Systemic Acquired Resistance
Hortscience: A Publication of the American Society for Hortcultural Science
Horticulture
Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics